Table 2 Characterization of the total sample, divided by transtibial vs transfemoral amputation vs able-bodied group and by control vs intervention groups.
Variables | Groups | P-value | Groups | P-value | |||
|---|---|---|---|---|---|---|---|
Transtibial (N = 6) | Transfemoral (N = 8) | Able-bodied (N = 10) | Control (N = 7) | Intervention (N = 7) | |||
Age (years) | 38 ± 13 | 40 ± 11 | 35 ± 13 | 0.655AN | 37 ± 13 | 42 ± 9 | 0.478TT |
Height (m) | 1.72 ± 0.07 | 1.74 ± 0.11 | 1.76 ± 0.04 | 0.583AN | 1.69 ± 0.08 | 1.77 ± 0.09 | 0.092TT |
Body mass (kg) | 75.9 ± 9.4 | 77.0 ± 12.7 | 84.5 ± 9.9 | 0.224AN | 75.1 ± 9.6 | 78.0 ± 12.5 | 0.642TT |
Body mass index (kg/m2) | 25.7 ± 2.6 | 25.2 ± 1.9 | 27.3 ± 4.1 | 0.345AN | 26.2 ± 1.7 | 24.6 ± 2.3 | 0.180TT |
Amputation time (months) | 12 (7 a 59) | 11 (6 a 69) | – | 0.896 MW | 12 (6 a 120) | 12 (8 a 24) | 0.737TT |
Amputation cause [Nº. (%)] | |||||||
Traumatic | 4 (66.7) | 7 (87.5) | – | 0.538EF | 6 (85.7) | 5 (71.4) | 1.000EF |
Vascular | 2 (33.3) | 1 (12.5) | 1 (14.3) | 2 (28.6) | |||
Type of amputation [Nº. (%)]c | |||||||
Transfemoral | – | – | – | – | 3 (42.9) | 5 (71.4) | 0.280EF |
Transtibial | – | – | – | – | 4 (57.1) | 2 (28.6) | |